SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 134 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,422 | -99.1% | 5,705 | -98.0% | 0.00% | -100.0% |
| Q2 2023 | $376,628 | -74.6% | 289,714 | -65.6% | 0.00% | -83.3% |
| Q1 2023 | $1,480,618 | +113.7% | 841,260 | +281.2% | 0.01% | +50.0% |
| Q4 2022 | $692,945 | +67.0% | 220,683 | +160.3% | 0.00% | +100.0% |
| Q3 2022 | $415,000 | +33.0% | 84,793 | +12.4% | 0.00% | 0.0% |
| Q2 2022 | $312,000 | -21.6% | 75,420 | +10.2% | 0.00% | -33.3% |
| Q1 2022 | $398,000 | +101.0% | 68,434 | +210.9% | 0.00% | +50.0% |
| Q3 2021 | $198,000 | -48.2% | 22,012 | -10.0% | 0.00% | -60.0% |
| Q4 2020 | $382,000 | +44.2% | 24,452 | -12.8% | 0.01% | +25.0% |
| Q3 2020 | $265,000 | -35.7% | 28,029 | -39.1% | 0.00% | -33.3% |
| Q2 2020 | $412,000 | – | 46,006 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alexandria Capital, LLC | 1,003,725 | $15,663,000 | 1.66% |
| Golden State Equity Partners | 123,817 | $1,932,000 | 1.33% |
| Rhenman & Partners Asset Management AB | 821,888 | $12,826,000 | 1.05% |
| WASATCH ADVISORS LP | 10,072,381 | $157,180,000 | 0.77% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 29,636 | $462,000 | 0.73% |
| Ceeto Capital Group, LLC | 80,000 | $1,248,000 | 0.63% |
| EMC Capital Management | 48,992 | $765,000 | 0.58% |
| Fort Sheridan Advisors LLC | 71,173 | $1,111,000 | 0.54% |
| Vanguard Capital Wealth Advisors | 34,680 | $584,000 | 0.54% |
| Casdin Capital, LLC | 1,080,000 | $16,853,000 | 0.50% |